Related Experiment Video
Updated: Jun 21, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
[Oral contraceptives and breast cancer]
D Zoricić1, B Ambrozić, D Perić
1Djelatnost za ginekologiju i porodnistvo, Opća bolnica Pula.
Abstract:
Hormonal contraception is important for the way of life of many modern women. Since the oral contraceptives were introduced 30 years ago, millions of women were using the pill and large number of experimental, clinical and epidemiological studies have analyzed the risks of their administration. The question whether the usage of exogenous sex-steroids as hormonal contraception may favor the development of breast malignancy is a much debated problem, but a complete answer to the question of the relationship between contraception pill and breast cancer is at present still unresolved. Most studies have not found an overall increased risk of breast cancer associated with the use of the pill, but several recent studies suggested a link between the early-onset breast cancer and a long-term use of oral contraceptives at young ages. The risks for some subpopulations of women seem small (relative risk about 2.0 or less), but consistency of the findings has enforced further study. Women under the age of 35, if they have used the pill long-term or if they are at increased risk of breast cancer for other reasons, should discuss the risks of oral contraceptive use. Contraindications of pill usage must be strictly respected and their users carefully watched, including routine breast examinations. It is equally important to inform our patients about important and numerous positive impacts of pill usage on women's health, to reassure these women and prevent cancerophobia. Sufficient time has now elapsed to permit prospective epidemiological studies with large numbers of women who took the pill for many years beginning at a young age, and follow them as they come in age when breast cancer is most common. So we should carefully examine their results.
More Related Videos
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
13:43Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
Published on: April 1, 2022
Related Concept Videos
Birth Control Methods
Cancer Prevention
Some...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Disorders of the Female Reproductive System
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Inhibition of Cdk Activity